Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin with Chemotherapy in Inoperable Gastric and Gastro-oesophageal Cancer
NCT00718354Phase 3Completed
- Sponsor
- Thrombosis Research Institute
- Start
- Jul 2008
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Thrombosis Research Institute. Started Jul 2008; status: completed.
02
Drugs
enoxaparin
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT00718354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718354.